American Diabetes Association (ADA)
Pathway to Stop Diabetes
Accelerator Award
On This Page
$1.625M limited ADA "Accelerator" funding opportunity for exceptional, independent early career investigators (assistant professors with PI eligibility-with UTL, MCL or NTL-Research appointments) with demonstrated independent productivity in diabetes research.
The 2018 internal deadline has passed. This webpage is for your reference only.
This is one of three related limited ADA Pathway to Stop Diabetes Awards.
The other two programs are:
- "Initiator Award" (postdoc-to-faculty transition award) more >>
- “Visionary Award" (for established senior investigators-faculty with PI eligibility-who are new to diabetes research and who would like to apply their expertise to innovative diabetes-related research topics) more >>
# of applicants: 1*
*Stanford is permitted ONE total nomination. It can be either an "Initiator", an "Accelerator", or an "Visionary" applicant.
Timeline
Internal deadline: Tuesday, April 3, 2018, 5 p.m. (see the internal submission guidelines below)
For applicant selected:
Institutional representative (RPM/RMG) deadline: June 25, 2018
Sponsor deadline: July 2, 2018
Start date for funding: Jan. 1, 2019
Amount of funding:
up to $325, 000 per year (including 30% indirect costs) x 5 years for a total of $1.625M
Guidelines
Download the application guidelines from this ADA webpage:
http://professional.diabetes.org/meetings/pathway-stop-diabetes%C2%AE
However, please see the eligibility section and internal submission guidelines on this webpage.
- Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
- Only one person can be specified as the PI (co-PIs are not permitted)
- Applicants must hold independent faculty positions (assistant professors with PI eligibility-with UTL, MCL and NTL-Research appointments) and have demonstrated independent productivity in diabetes research.
- Candidate’s appointment at the Sponsoring Institution must be full-time. Rare exceptions to full-time positions may be granted on a case-by-case basis and must be pre-approved by Pathway administration staff prior to application submission.
- Not eligible: Instructors, clinical instructors, academic staff-research (i.e., basic scientists, senior research associates) are not eligible because Stanford does not consider them to be independent or faculty positions.
- Other research support: Applicants may currently hold independent NIH funding (K, U, or R awards, including an initial NIH R01/U01) but must not have applied for, or received, an NIH R01/U01 renewal or a second R01/U01 award.
- Applicants must agree to devote at least 75% of total time and effort towards research during the period of Association funding. In other words, 75% of the PI’s time overall must be dedicated to research. This percentage includes time dedicated to the Association-funded grant in addition to grants supported by other funding agencies.
- The program intends to attract individuals with a broad range of expertise in various science and technology disciplines, including medicine, biology, chemistry, computing and engineering, to the field of diabetes research.
- No citizenship restriction. However, individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional certification of permission to work within the U.S. will be required prior to activation of the award.
- See the purpose, research topic and research type sections below.
Purpose
Pathway Accelerator awards are intended to provide flexible, long-term salary and research support to early career researchers who are proposing innovative and ambitious diabetes-related research programs, and who have distinguished themselves as exceptionally talented and promising research investigators.
Candidates for Accelerator awards should be in the process of establishing successful, independent diabetes research programs, and have records of independent productivity in research. For the purpose of this award, demonstration of independent productivity should include that the candidate is currently in an independent faculty position, has demonstrated the ability to perform a particular set of experiments at a high-quality level, including senior author publications (independent of training mentors) and/or has demonstrated the ability to obtain independent funding/support for their work.
Research Topics:
The Pathway to Stop Diabetes Research Program will consider applications directed toward all topics rele-vant to prevention, treatment and cure of all types of diabetes (type 1, type 2, and gestational diabetes), diabetes-related disease states (obesity, pre-diabetes, and other insulin resistant states) and the complica-tions of the disease. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics and physics.
Types of research: can be basic, clinical, or translational. For the purpose of this award, clinical research is defined as research directly involving humans, and includes educational, psychosocial, behavioral, epidemiologic, and health services research as well as clinical studies of normal physiology and mechanisms of disease. Translational research is defined as research that accelerates the transition of scientific discoveries into clinical applications, by efficiently advancing knowledge of efficacy to the next level of clinical application.
Review Criteria
Scientific excellence is the primary benchmark to be evaluated for all Pathway applications, with an emphasis on the investigator’s potential to significantly impact the field of diabetes research. The proposed research strategy serves as a reflection of the individual’s capacity for innovation, creativity and collaboration. The review will include the following components:
Principal Investigator:
- Proven ability to establish independent research program
- Proven ability for creativity, collaboration and innovation
- Institutional commitment
Research Strategy:
- Innovation and creativity
- Potential impact for understanding/treatment of diabetes
- Clarity of thought and approach
INTERNAL SUBMISSION GUIDELINES
By Tuesday, April 3, 2018, 5 p.m., please submit one PDF file containing the following in the order listed below to:
Jeanne Heschele
Research Management Group (RMG)
jheschele@stanford.edu
650-245-2351
File name: Last name_ADA_Accelerator.pdf
Faculty: You do not have to prepare a budget, or submit a PDRF form or submit your proposals through your institutional representative (RPM or OSR). You can submit them directly to Jeanne.
1) Title Page
American Diabetes Association (ADA) Pathway to Stop Diabetes" Accelerator Award"
Indicate Diabetes category relevant to the research: both Type 1 and Type 2 Diabetes; Type 1 Diabetes, Type 2 diabetes, Gestational Diabetes, obesity, pre-diabetes/insulin resistance
Research type: basic, clinical or translational
Project Title:
PI name, appointment, Department, address, phone, email
2) Nomination letter printed on your department or division's letterhead signed by your Division Chief or your Department Chair addressed to Dr. Peter Sarnow and the Awards Committee members.
Provide rationale for your nomination of candidate, including why candidate is uniquely suited for the award.
The applicant’s ability to make significant contributions in diabetes research
Certify that the candidate has the appropriate full-time position at the sponsoring institution as required by the award.
Outline the candidate’s responsibilities and ensure that at least 75% of the nominee’s total time and effort will be allocated to research during the term of this award.
Provide assurance of an academic commitment to the candidate and to the research proposal.
3) "Research Strategy" Proposal- up to 4 page maximum
Formatting guidelines: Single-spaced, 1/2 inch margins, Font size 11 or larger, Ariel or Helvetica font. Figures can be included in the 4 page limit. References can be on a separate page and are not included in the four page limit.
The research strategy should provide a high level description of your scientific question(s) and the strategy(ies) and approach(es) that you will employ to address this question. It should be written with a level of detail appropriate for reviewers who are knowledgeable of the field, but who may not be directly involved in the proposed area of research. The Research strategy section is flexible in format, does not require a detailed project plan or description of methods, or preliminary data. Figures are allowed, but must be included in the 4 page limit.
The research strategy should address the following components:
a) Scientific question(s)/specific problem(s) to be addressed
b) Specific approach(es) that will be employed
c) Significance and potential impact of the work
d) The potential risks and challenges, and how they will be overcome
4) NIH Biosketch
You can download instructions and a blank Word document of NIH biosketch from this webpage:
http://grants.nih.gov/grants/funding/424/index.htm#biosketch
5) Other support (include current and pending support, sponsor, term, amount of funding)
Selection process
Your proposals will be reviewed by the School of Medicine Awards Committee. That committee will select the applicant to represent Stanford. (Note: there can only be one applicant- either an Accelerator, an Initiator, or a "Visionary" applicant)
